title: Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases.
authors.forename: P
authors.initials: P
authors.lastname: Chevallier
authors.forename: N
authors.initials: N
authors.lastname: Robillard
authors.forename: G
authors.initials: G
authors.lastname: Houille
authors.forename: S
authors.initials: S
authors.lastname: Ayari
authors.forename: T
authors.initials: T
authors.lastname: Guillaume
authors.forename: J
authors.initials: J
authors.lastname: Delaunay
authors.forename: J-L
authors.initials: JL
authors.lastname: Harousseau
authors.forename: H
authors.initials: H
authors.lastname: Avet-Loiseau
authors.forename: M
authors.initials: M
authors.lastname: Mohty
authors.forename: R
authors.initials: R
authors.lastname: Garand
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000627:therapeutic use*; D015703:Antigens, CD / Q000032:analysis / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology*; D055815:Young Adult
chemical_list: D000906:Antibodies; D015703:Antigens, CD